Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|October 19, 2007
Co-administration of SR141716 with peptide YY3-36 or oxyntomodulin has additive effects on food intake in miceN E White, W S Dhillo, Y-L Liu, et al.Psychopharmacology|January 1, 1993
BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like propertiesT P Blackburn, G S Baxter, G A Kennett, et al.Journal of Medicinal Chemistry|July 7, 1995
5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activityI T Forbes, P Ham, D H Booth, et al.British Journal of Pharmacology|February 1, 1996
In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like propertiesG A Kennett, M D Wood, F Bright, et al.Neuropharmacology|April 1, 1997
SB 242084, a selective and brain penetrant 5-HT2C receptor antagonistG A Kennett, M D Wood, F Bright, et al.Neuropharmacology|August 8, 2001
SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxietyM D Wood, C Reavill, B Trail, et al.Journal of Medicinal Chemistry|December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001
The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the ratK J Stanhope, N R Mirza, M J Bickerdike, et al.Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonistsS M Bromidge, S Davies, D M Duckworth, et al.Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agentsS M Bromidge, S Dabbs, S Davies, et al.Pageof 7